Related references
Note: Only part of the references are listed.Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
Ashley D. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High-Dose Daptomycin for Cardiac Implantable Electronic Device-Related Infective Endocarditis
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
Ravina Kullar et al.
CLINICAL INFECTIOUS DISEASES (2011)
High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
Ravina Kullar et al.
PHARMACOTHERAPY (2011)
Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Natividad Benito et al.
ANNALS OF INTERNAL MEDICINE (2009)
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
Pamela A. Moise et al.
ANNALS OF PHARMACOTHERAPY (2009)
Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis
H. F. Chambers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Safety of High-Dose Intravenous Daptomycin Treatment: Three-Year Cumulative Experience in a Clinical Program
D. A. Figueroa et al.
CLINICAL INFECTIOUS DISEASES (2009)
Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)
John F. Mohr et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Contemporary Epidemiology and Prognosis of Health Care-Associated Infective Endocarditis
Nuria Fernandez-Hidalgo et al.
CLINICAL INFECTIOUS DISEASES (2008)
Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin
Burke A. Cunha et al.
HEART & LUNG (2008)
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria
D. E. Katz et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin
Burke A. Cunha et al.
HEART & LUNG (2007)
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis:: an in vitro and in vivo simulation using historical and current dosing strategies
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria
Lawrence I. Mortin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A better future for patients with restless legs syndrome
John W. Winkelman
AMERICAN JOURNAL OF MEDICINE (2007)
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Hajo Grundmann et al.
LANCET (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome
R Khatib et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)
Short-course gentamicin in combination with Daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
BT Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Staphylococcus aureus endocarditis -: A consequence of medical progress
VG Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Daptomycin dose-effect relationship against resistant gram-positive organisms
R Cha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Monitoring antimicrobial use and resistance: Comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci
SK Fridkin et al.
EMERGING INFECTIOUS DISEASES (2002)
Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations
RL Akins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis
JS Li et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
